Impact of portal glucose delivery on glucose metabolism in conscious, unrestrained mice

American Journal of Physiology - Endocrinology and Metabolism

Volumn 291, Issue 6, 2006, Pages

  Chueh, Fu Yu ^a   Malabanan, Carlo ^a   McGuinness, Owen P ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Fasting; Hyperglycemia; Portal vein

Indexed keywords

GLUCOSE; INSULIN;

ANIMAL EXPERIMENT; ARTERY CATHETERIZATION; ARTICLE; CONTROLLED STUDY; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE INFUSION; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; INSULIN BLOOD LEVEL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; VEIN CATHETERIZATION;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CAROTID ARTERIES; CATHETERIZATION; GLUCAGON; GLUCOKINASE; GLUCOSE; GLUCOSE-6-PHOSPHATASE; HEXOKINASE; INSULIN; JUGULAR VEINS; LIVER GLYCOGEN; MALE; MICE; MICE, INBRED C57BL; PORTAL VEIN;

EID: 33845437164     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00608.2005     Document Type: Article

References (29)

1. Ayala JE, Bracy D, McGuinness OP, and Wasserman DH. Considerations in the design of hyperinsulinemic-euglycemic clamps in the conscious mouse. Diabetes 55: 390-397, 2006.
2. Barzilai N and Rossetti L. Role of glucokinase and glucose-6-phosphatase in the acute and chronic regulation of hepatic glucose fluxes by insulin. J Biol Chem 268: 25019-25025, 1993.
3. Bjorkman O and Eriksson LS. Influence of a 60-hour fast on insulin-mediated splanchnic and peripheral glucose metabolism in humans. J Clin Invest 76: 87-92, 1985.
4. Burcelin R, Da Costa A, Drucker D, and Thorens B. Glucose competence of the hepatoportal vein sensor requires the presence of an activated glucagon-like peptide-1 receptor. Diabetes 50: 1720-1728, 2001.
5. Burcelin R, Dolci W, and Thorens B. Glucose sensing by the hepatoportal sensor is GLUT2-dependent: in vivo analysis in GLUT2-null mice. Diabetes 49: 1643-1648, 2000.
6. Burcelin R, Dolci W, and Thorens B. Portal glucose infusion in the mouse induces hypoglycemia: evidence that the hepatoportal glucose sensor stimulates glucose utilization. Diabetes 49: 1635-1642, 2000.
7. Cardin S, Emshwiller M, Jackson PA, Snead WL, Hastings J, Edgerton DS, and Cherrington AD. Portal glucose infusion increases hepatic glycogen deposition in conscious unrestrained rats. J Appl Physiol 87: 1470-1475, 1999.
8. 14C glucose. Recent Prog Horm Res 19: 445-488, 1963.
9. DeFronzo RA, Ferrannini E, Hendler R, Wahren J, and Felig P. Influence of hyperinsulinemia, hyperglycemia, and the route of glucose administration on splanchnic glucose exchange. Proc Natl Acad Sci USA 75: 5173-5177, 1978.
10. Dunning BE, Moore MC, Ikeda T, Neal DW, Scott MF, and Cherrington AD. Portal glucose infusion exerts an incretin effect associated with changes in pancreatic neural activity in conscious dogs. Metabolism 51: 1324-1330, 2002.
11. Fery F, Plat L, and Balasse EO. Effect of fasting on the intracellular metabolic partition of intravenously infused glucose in humans. Am J Physiol Endocrinol Metab 277: E815-E823, 1999.
12. Gardemann A, Strulik H, and Jungermann K. A portal-arterial glucose concentration gradient as a signal for an insulin-dependent net glucose uptake in perfused rat liver. FEBS Lett 202: 255-259, 1986.
13. Halseth AE, Bracy DP, and Wasserman DH. Overexpression of hexokinase II increases insulin- and exercise-stimulated muscle glucose uptake in vivo. Am J Physiol Endocrinol Metab 276: E70-E77, 1999.
14. Heijboer AC, Donga E, Voshol PJ, Dang ZC, Havekes LM, Romijn JA, and Corssmit EP. Sixteen hours of fasting differentially affects hepatic and muscle insulin sensitivity in mice. J Lipid Res 46: 582-588, 2005.
15. Hendrick GK, Frizzell RT, Williams PE, and Cherrington AD. Effect of hyperglucagonemia on hepatic glycogenolysis and gluconeogenesis after a prolonged fast. Am J Physiol Endocrinol Metab 258: E841-E849, 1990.
16. Ionut V, Hucking K, Liberty IF, and Bergman RN. Synergistic effect of portal glucose and glucagon-like peptide-1 to lower systemic glucose and stimulate counter-regulatory hormones. Diabetologia 48: 967-975, 2005.
17. McGuinness OP, Fujiwara T, Murrell S, Bracy D, Neal D, O'Connor D, and Cherrington AD. Impact of chronic stress hormone infusion on hepatic carbohydrate metabolism in the conscious dog. Am J Physiol Endocrinol Metab 265: E314-E322, 1993.
18. Moore MC, Cardin S, Edgerton DS, Farmer B, Neal DW, Lautz M, and Cherrington AD. Unlike mice, dogs exhibit effective glucoregulation during low-dose portal and peripheral glucose infusion. Am J Physiol Endocrinol Metab 286: E226-E233, 2004.
19. Moore MC, Cherrington AD, Cline G, Pagliassotti MJ, Jones EM, Neal DW, Badet C, and Shulman GI. Sources of carbon for hepatic glycogen synthesis in the conscious dog. J Clin Invest 88: 578-587, 1991.
20. Moore MC, Hsieh PS, Neal DW, and Cherrington AD. Nonhepatic response to portal glucose delivery in conscious dogs. Am J Physiol Endocrinol Metab 279: E1271-E1277, 2000.
21. Morgan CR and Lazarow A. Immunoassay of pancreatic and plasma insulin following alloxan injection of rats. Diabetes 14: 669-671, 1965.
22. Niswender KD, Shiota M, Postic C, Cherrington AD, and Magnuson MA. Effects of increased glucokinase gene copy number on glucose homeostasis and hepatic glucose metabolism. J Biol Chem 272: 22570-22575, 1997.
23. Ogihara N, Kawamura W, Kasuga K, Hayashi Y, Arakawa H, and Kikuchi M. Characterization of the portal signal during 24-h glucose delivery in unrestrained, conscious rats. Am J Physiol Endocrinol Metab 286: E932-E940, 2004.
24. Pagliassotti MJ and Cherrington AD. Regulation of net hepatic glucose uptake in vivo. Ann Rev Physiol 54: 847-860, 1992.
25. Rothman DL, Magnusson I, Katz LD, Shulman RG, and Shulman GI. Quantitation of hepatic glycogenolysis and gluconeogenesis in fasting humans with 13C NMR. Science 254: 573-576, 1991.
26. Sarin SK, Sabba C, and Groszmann RJ. Splanchnic and systemic hemodynamics in mice using a radioactive microsphere technique. Am J Physiol Gastrointest Liver Physiol 258: G365-G369, 1990.
27. Shulman GI and Rossetti L. Influence of the route of glucose administration on hepatic glycogen repletion. Am J Physiol Endocrinol Metab 257: E681-E685, 1989.
28. Vella A, Shah P, Basu R, Basu A, Camilleri M, Schwenk WF, and Rizza RA. Effect of enteral vs. parenteral glucose delivery on initial splanchnic glucose uptake in nondiabetic humans. Am J Physiol Endocrinol Metab 283: E259-E266, 2002.
29. Zangeneh F, Basu R, Shah P, Arora P, Camilleri M, and Rizza RA. Enteral infusion of glucose at rates approximating EGP enhances glucose disposal but does not cause hypoglycemia. Am J Physiol Endocrinol Metab 285: E280-E286, 2003.